As a step forward, a study increased the heterogeneity of the tumor-on-chip model by using four cell types to establish the 3D tumor-on-chip model including cancer cells (Her2+ subtype), CAFs, immune cell, and endothelial cells. This evidence concerns the gene ERBB2 and cancer.